{"id":"W2051950694","doi":"10.1016/j.ygyno.2014.03.121","title":"Evaluation of CA-125 response in the TRINOVA-1 study of weekly paclitaxel plus trebananib or placebo in women with recurrent ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Paclitaxel; Placebo; Clinical endpoint; Ovarian cancer; Oncology; Internal medicine; Post-hoc analysis; Response Evaluation Criteria in Solid Tumors; Cancer; Clinical trial; Phases of clinical research; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001972724,0.0009515057,0.002519546,0.0004509058,0.0002077481,0.0006240779,0.0008257775,0.0009479748,0.002192467],"category_scores_gemma":[0.001989174,0.0005438796,0.001558779,0.0003542262,0.0005891821,0.0006881173,0.0003199647,0.002391706,0.0003608194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008047759,"about_ca_system_score_gemma":0.0007929406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001012795,"about_ca_topic_score_gemma":0.002575723,"domain_scores_codex":[0.9991693,0.00053491,0.00004198329,0.0001102308,0.00005325793,0.00009033148],"domain_scores_gemma":[0.9991621,0.0003084261,0.0002115859,0.00007478169,0.00003421033,0.0002090445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.945927,0.003744386,0.004482664,0.0003547376,0.001603811,0.00004710442,0.00007774083,0.0006090605,0.005493013,0.00007460885,0.0004181445,0.03716779],"study_design_scores_gemma":[0.5532875,0.4024093,0.03589286,0.00008145722,0.002691217,0.0001706553,0.00008749975,0.001451467,0.002146099,0.000243139,0.00148911,0.00004975298],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943925,0.003383111,0.0001505255,0.0003105495,0.0001533627,0.0002735704,0.0003090006,0.00004797015,0.000979365],"genre_scores_gemma":[0.996733,0.001134132,0.0002392798,0.0002170787,0.0001316326,0.0002721206,0.0004009022,0.00001342599,0.0008584433],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002519546,"threshold_uncertainty_score":0.01043284,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06933795730224084,"score_gpt":0.3808796781457527,"score_spread":0.3115417208435119,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}